Emcure Pharmaceuticals Ltd banner
E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 507.9 INR -1.54% Market Closed
Market Cap: ₹285.9B

Wall Street
Price Targets

EMCURE Price Targets Summary
Emcure Pharmaceuticals Ltd

Wall Street analysts forecast EMCURE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EMCURE is 1 830.73 INR with a low forecast of 1 636.2 INR and a high forecast of 2 028.6 INR.

Lowest
Price Target
1 636.2 INR
9% Upside
Average
Price Target
1 830.73 INR
21% Upside
Highest
Price Target
2 028.6 INR
35% Upside
Emcure Pharmaceuticals Ltd Competitors:
Price Targets
THFF
First Financial Corp
20% Upside
SONO
Sonos Inc
47% Upside

Revenue
Forecast

15% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
15% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 2 years the compound annual growth rate for Emcure Pharmaceuticals Ltd's revenue is 15%. The projected CAGR for the next 3 years is 14%.

Operating Income
Forecast

9% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
9% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 2 years the compound annual growth rate for Emcure Pharmaceuticals Ltd's operating income is 9%. The projected CAGR for the next 3 years is 22%.

Net Income
Forecast

13% / Year
Past Growth
28% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
13% / Year
Past Growth
28% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 2 years the compound annual growth rate for Emcure Pharmaceuticals Ltd's net income is 13%. The projected CAGR for the next 3 years is 28%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EMCURE's stock price target?
Price Target
1 830.73 INR

According to Wall Street analysts, the average 1-year price target for EMCURE is 1 830.73 INR with a low forecast of 1 636.2 INR and a high forecast of 2 028.6 INR.

What is Emcure Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
14%

For the last 2 years the compound annual growth rate for Emcure Pharmaceuticals Ltd's revenue is 15%. The projected CAGR for the next 3 years is 14%.

What is Emcure Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
22%

For the last 2 years the compound annual growth rate for Emcure Pharmaceuticals Ltd's operating income is 9%. The projected CAGR for the next 3 years is 22%.

What is Emcure Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
28%

For the last 2 years the compound annual growth rate for Emcure Pharmaceuticals Ltd's net income is 13%. The projected CAGR for the next 3 years is 28%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett